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A critical role for reactive oxygen species (ROS) in
photoreceptor apoptosis has been established. However,
the exact molecular mechanisms triggered by oxidative
stress in photoreceptor cell death remain undefined.
This study delineates the molecular events that occur
after treatment of the photoreceptor cell line 661W with
the nitric oxide donor sodium nitroprusside (SNP). Cy-
tosolic calcium levels increased during photoreceptor
apoptosis, leading to activation of the calcium-depend-
ent proteases calpains. Furthermore, caspase activation
also occurred following SNP insult. However, although
treatment with the pan-caspase inhibitor benzyloxycar-
bonyl-Val-Ala-Asp fluoromethyl ketone inhibited
caspase activity per se in SNP-treated 661W cells, it did
not prevent apoptosis. On the other hand, CR-6 (3,4-
dihydro-6-hydroxy-7-methoxy-2,2-dimethyl-1(2H)-ben-
zopyran) acted as a scavenger of ROS and reduced 661W
photoreceptor apoptosis induced by SNP by preventing
the activation of a pathway in which calpains have a key
role. In summary, we report for the first time that both
caspases and calpains are involved in 661W photorecep-
tor apoptosis and that calpain activation can be pre-
vented by the ROS scavenger CR-6.
The cell death process of apoptosis is characterized by a
series of morphological and biochemical changes, including
membrane blebbing, loss of plasma membrane asymmetry,
chromatin cleavage, and DNA fragmentation (1, 2). Apoptosis
plays a central role in tissue modeling during development and,
together with the cell-generating process of mitosis, is respon-
sible for the maintenance of cell numbers in multicellular or-
ganisms. Deregulation of apoptosis has been well documented
in several human pathologies, including cancer, neurodegen-
erative diseases, and AIDS (3, 4). Apoptosis also appears to be
responsible for the cell loss seen in several disorders of the
retina, including retinitis pigmentosa (a heterogeneous group
of inherited disorders), glaucoma, and macular degeneration
(5–8). Experiments aimed at unraveling the signaling path-
ways of apoptosis have identified several distinct mechanisms,
and it has largely been accepted that caspases play a key role
in both the initiation and execution pathways of apoptosis.
However, the involvement of caspases does not seem to be
clear-cut in some tissue systems. For example, there is still
considerable controversy as to whether caspases play a role in
retinal cell death (9–12). There is also some uncertainty about
the role of caspases in neurodegenerative conditions (13–15).
Recent work from our laboratory has indicated that photore-
ceptor death in animal models of retinitis pigmentosa proceeds
in the absence of caspase activity, suggesting a caspase-inde-
pendent mechanism of cell destruction (11, 12, 16). The exact
mechanisms operating in photoreceptor death are still unclear
but may involve calpains rather than caspases as the executing
enzymes. These studies also suggested a key role for reactive
oxygen species (ROS)1 and reactive nitrogen intermediates
(RNI) since inhibitors of nitric-oxide synthase blocked the cell
death seen. These results are quite interesting since several
studies have indicated that the eye is particularly sensitive to
oxidative stress and therefore, modifications of the cellular
redox state of the eye have been reported to play an important
role in retinal degeneration processes (17–20). Additional sup-
port for the involvement of ROS and oxidative stress in photo-
receptor apoptosis comes from several studies in which anti-
oxidants appeared to retard or inhibit the degenerative
pathology (21–23). However, the mechanisms of action of these
anti-apoptotic molecules are unclear, and further work is nec-
essary to resolve whether oxidative stress acts as a common
mediator of retinal degeneration in retinitis pigmentosa.
The retina is composed of several different cell types, and
this complicates any studies aimed at delineating the underly-
ing mechanism of photoreceptor apoptosis. The production and
characterization of the photoreceptor cell line 661W by Al-
Ubaidi et al. (24) have greatly facilitated work in this area. This
cell line expresses several markers of photoreceptors and has
proved useful for in vitro studies investigating photoreceptor
apoptosis (19, 20, 25, 26). In the context of this work, we have
used this cell line to investigate the role played by oxidative
stress in photoreceptor apoptosis induced by the nitric oxide
donor sodium nitroprusside (SNP). This constitutes a direct
extension of previous work from this laboratory (11) in which
we showed that nitric oxide and ROS play a key role in driving
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photoreceptor apoptosis in vivo. In this study, we show that
SNP induced ROS production in the mitochondrion and that
this in turn triggered apoptosis, with both calpains and
caspases playing a role. Treatment with the pan-caspase inhib-
itor benzyloxycarbonyl-Val-Ala-Asp fluoromethyl ketone (Z-
VAD-fmk) inhibited the activation of caspases, but does not
appear to be a useful strategy to prevent oxidative stress-
induced apoptosis in 661W photoreceptor cells. On the other
hand, in the context of this work, we show that CR-6 (a vitamin
E analog that has been shown to prevent glutamate neurotox-
icity in cultured neurons due to its role as a nitric oxide scav-
enger (27)), interfered with oxidative stress-induced apoptosis
in 661W cells by preventing the activation of the calpain-
mediated apoptotic pathway.
EXPERIMENTAL PROCEDURES
Drugs, Reagents, and Antibodies—SNP was purchased from Sigma
(Poole, United Kingdom). The synthesis of CR-6 has been described
elsewhere (28). Cell Signaling Technology (Beverly, MA) provided anti-
poly(ADP-ribose) polymerase (PARP) (catalog no. 9542), anti-caspase-3
(catalog no. 9662), anti-caspase-9 (catalog no. 9504), and anti-
caspase-12 (catalog no. 2202) antibodies. Anti-Calpain-1 (catalog no.
208753) and anti-calpain-2 (catalog no. 208755) antibodies were pur-
chased from Calbiochem. Anti-calpastatin (sc-7561) and anti-calpain
small regulatory subunit (C-20; sc-7528) antibodies were from Santa
Cruz Biotechnology (Santa Cruz, CA). Anti--actin antibody was from
Sigma. Peroxidase-conjugated anti-rabbit, anti-goat, and anti-mouse
secondary antibodies were obtained from Dako Corp. The broad-spec-
trum caspase inhibitor Z-VAD-fmk was purchased from Bachem Ltd.
(Meyerside, United Kingdom). Alexis Co. (La¨ufefingen, Switzerland)
provided the caspase-3 substrate acetyl-Asp-Glu-Val-Asp p-nitroanilide
(Ac-DEVD-pNA).
Cell Culture—661W cells were kindly provided by Muayyad Al-
Ubaidi, Department of Cell Biology, University of Oklahoma (Okla-
homa City, OK). 661W cells were routinely grown in Dulbecco’s modi-
fied Eagle’s medium supplemented with 10% heat-inactivated fetal calf
serum (both from Sigma) and 1% penicillin/streptomycin at 37 °C in a
humidified 5% CO2 atmosphere as described (20). SNP was used to
induce apoptosis at the doses indicated; SNP stock was prepared at 100
mM in phosphate-buffered saline (PBS) (pH 7.4). Pretreatment of 661W
photoreceptors with CR-6 was done for 15 min at 37 °C as described
above. A 100 mM CR-6 stock was prepared in Me2SO. Treatments
carried out in 6-well plates (Nalge Nunc International, Hereford,
United Kingdom) were as follow. Cells (75  104/well) were seeded and
allowed to attach for 20 h at 37 °C. Following insult, cells were detached
with a trypsin/EDTA solution (Sigma) and collected together with their
supernatants for flow cytometric analysis. Cells for Western blot anal-
ysis were grown in 75-cm2 flasks (Sarstedt AG & Co., Nu¨mbrecht,
Germany). Initially, cells (8  105/flask) were seeded and allowed to
attach before treatment. Samples were collected 24 or 48 h post-insult.
Analysis of Generated RNI: Griess Reaction—Determination of the
presence of RNI was done by means of the Griess reaction (29). Briefly,
cells (5  104) were incubated for 15 min in the dark at room temper-
ature with 40 l of Griess reagent (Alexis Corp.). Nitrites present in the
samples react with sulfanilic acid and N-(1-naphthly)ethylenediamine
dihydrochloride in the presence of phosphoric acid, which produces a
colored azo dye that can be measured at 548 nm.
Analysis of Intracellular ROS Generation—Measurement of super-
oxide anion levels was carried out as described previously (30). Briefly,
cells were loaded with 10 M dihydroethidium (DHE) (Molecular
Probes, Inc., Leiden, The Netherlands), prepared from a 10 mM stock in
Me2SO, for 15 min at 37 °C. Superoxide anion oxidizes DHE intracel-
lularly to produce ethidium bromide, which fluoresces upon interaction
with DNA. The fluorescence due to ethidium bromide in a BD Bio-
sciences FACScan flow cytometer with excitation and emission settings
of 488 and 590 nm, respectively, was monitored to assess superoxide
anion levels. CellQuest software was used for data analysis, and 10,000
events/sample were acquired.
Cell Death Measurement—Propidium iodide (Sigma) was used to
quantify cell death. Treated cells were collected as described above,
washed once with ice-cold PBS, and resuspended to a final concentra-
tion of 1  105 cells/ml. Propidium iodide (50 g/ml) was added imme-
diately before flow cytometric analysis. Fluorescence was measured at
FL2 (590 nm), and 10,000 events/sample were acquired.
Measurement of Intracellular Free Ca2—Intracellular Ca2 levels
were determined using the intracellular Ca2 probe Fluo-3/acetoxy-
methyl ester (Molecular Probes, Inc.), which binds Ca2 with a 1:1
stoichiometry. After trypsinization, cells were washed once with PBS
and resuspended in fresh buffer. Cells were incubated in the darkness
with 250 nM Fluo-3, prepared from a 500 M stock, for 30 min at 37 °C.
Fluorescence was measured at FL1 (530 nm) in a BD Biosciences
FACScan flow cytometer with excitation at 488 nm, and CellQuest
software was employed for subsequent data analysis. At least 10,000
events/sample were acquired.
Western Blot Analysis—After exposure to drug, whole cell extracts
were obtained and resolved by denaturing SDS-PAGE. Briefly, har-
vested cells were washed twice with ice-cold PBS; resuspended in cell
lysis buffer (50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM Na3VO4, 1
mM NaF, 1 mM EGTA, 1% Nonidet P-40, and 0.25% sodium deoxy-
cholate) containing antipain (1 g/ml), aprotinin (1 g/ml), chymostatin
(1 g/ml), leupeptin (0.1 g/ml), pepstatin (1 g/ml), and 0.2 mM 4-(2-
aminoethyl)benzenesulfonyl fluoride; and incubated on ice for 20 min.
Supernatants were recovered by a 10-min centrifugation (10,000 g) at
4 °C, and protein concentration was determined with the Bio-Rad pro-
tein assay using bovine serum albumin as a standard. Proteins (20–40
g) were diluted in 2 sample buffer (10% SDS and 100 mM each
dithiothreitol, glycerol, bromphenol blue, and Tris-HCl) and resolved on
6–12% SDS-polyacrylamide gels. Then proteins were transferred onto
nitrocellulose membranes (Schleicher & Schu¨ll, Dassel, Germany), and
the blots were blocked with 5% (w/v) nonfat dry milk in Tris-buffered
saline and 0.1% Tween 20 for 1 h at room temperature. Membranes
were incubated overnight at 4 °C with the appropriate dilution of pri-
mary antibody (1:5000 for anti-m-calpain and anti--calpain antibodies
and 1:1000 for all other antibodies). After three 5-min washes with
Tris-buffered saline and 0.1% Tween 20, the blots were incubated with
the corresponding peroxidase-conjugated secondary antibody (1:1000
dilution) for 1 h at room temperature. They were then washed again
three times with Tris-buffered saline and 0.1% Tween 20, rinsed briefly
with PBS, and developed with enhanced chemiluminescence reagents
(ECL, Amersham Biosciences, Buckinghamshire, United Kingdom). De-
tection of -actin (1:5000 antibody dilution) was used as control for
equal loading of protein.
Determination of Ac-DEVD-pNA Cleavage—661W cells (8  105)
were grown in 75-cm2 flasks and preincubated at 37 °C with the caspase
inhibitor Z-VAD-fmk (50 M) for 1 h prior to insult with 0.3 mM SNP.
Untreated and 0.3 mM SNP-treated 661W cells were used as negative
and positive controls, respectively. After a 24-h incubation, cells were
collected as described above and centrifuged at 500  g for 5 min. The
pellet was resuspended in 1 ml of ice-cold 1 PBS and transferred to a
microcentrifuge tube. Subsequently, the pellet was resuspended in 50
l of ice-cold lysis buffer (100 mM HEPES (pH 7.4), 1 M NaCl, 1%
CHAPS, 1 M dithiothreitol, 10 mM EDTA, and 1% Nonidet P-40) and
incubated on ice for 10 min. Following a 20-s sonication, cell lysates
were centrifuged for 10 min at 12,500  g. The protein content of each
sample was determined by the Bio-Rad protein assay using bovine
serum albumin as a standard. An equal quantity of protein (50 g) was
loaded into each well of a microtiter plate, and the final volume was
made up to 90 l with assay buffer (same as lysis buffer minus 1%
Nonidet P-40). Lysates were incubated with 0.2 mM Ac-DEVD-pNA at
37 °C for 20 h. Cleavage of the peptide substrate DEVD-pNA was
monitored by liberation of chromogenic pNA in a SpectraMax-340 plate
reader (Molecular Devices, Menlo Park, CA) by measuring absorption
at 405 nm.
Annexin V Assay—A combined staining with fluorescein isothiocya-
nate-conjugated annexin V and propidium iodide was performed as a
measure of apoptosis. Harvested cells were washed once with Ca2
binding buffer (10 mM HEPES (pH 7.4), 140 mM NaCl, and 2.5 mM
CaCl2) and resuspended in 100 l of the same buffer containing fluo-
rescein isothiocyanate-conjugated annexin V (IQ Products, Groningen,
The Netherlands). After a 15-min incubation in the dark at room
temperature, cells were diluted with 400 l of binding buffer, and
propidium iodide was added before flow cytometric analysis. Fluores-
cence was measured as described above.
RESULTS
SNP Induces ROS Production and Cell Death in the Photo-
receptor Cell Line 661W—Oxidative stress has been reported to
play an important role in photoreceptor cell death (18, 20).
Previous work carried out in this laboratory demonstrated that
nitric oxide mediates retinal degeneration in vivo and that ROS
significantly contribute to photoreceptor cell death (11). De-
spite these findings, the mechanisms leading to photoreceptor
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apoptosis are still not fully understood, and little is known
about oxidative pathways involved in retinal death. Therefore,
to gain a better understanding of the events triggered by RNI
and ROS in photoreceptors, the 661W cell line was treated with
increasing concentrations of the nitric oxide donor SNP (0.1–
0.5 mM) for 20 h. Previous studies have shown that SNP can
trigger apoptosis in neurons (31). The production of nitric oxide
metabolites was detected with the Griess reaction (29). In this
method, nitrite metabolites are detected with a colorimetric
reaction. Therefore, the value of the resulting absorbance is
proportional to the amount of RNI present in the samples. As
illustrated in Fig. 1A, an increase in nitric oxide metabolites
was observed in 661W photoreceptor cells upon treatment with
up to a concentration of SNP of 0.3 mM. Higher concentrations
of SNP did not significantly modify the concentration of RNI in
the cells.
In parallel with this study, superoxide anion formation was
monitored using the probe DHE (Fig. 1B). Contrary to results
observed for RNI, treatment with the lowest concentrations of
SNP (0.1–0.2 mM) did not significantly alter the levels of su-
peroxide anions present in 661W cells, and increased levels of
ROS were not detected until treatment with 0.3 mM SNP.
Incubation with 0.5 mM SNP increased superoxide anion levels
up to 73%, indicating a modification of the redox state in 661W
cells.
Quantification of cell death was performed by flow cytomet-
ric analysis. Propidium iodide was used to quantify the popu-
lation of cells in which membrane integrity was lost. As ex-
pected, treatment of 661W cells with SNP (0.1–0.5 mM) induced
cell death, with only 29% of cells surviving post-insult with 0.5
mM SNP (Fig. 1C). Nevertheless, an SNP concentration of 0.3
mM, which resulted in 50% cell death, was chosen for further
studies. Apoptotic cell death was then assessed by detection of
DNA fragmentation by DNA gel electrophoresis after treat-
ment with 0.3 mM SNP. The presence of the DNA ladder was
detected 48 h post-insult (data not shown). In conclusion, these
results confirm and extend previous observations showing the
involvement of ROS in photoreceptor cell death (11, 12, 16).
661W Photoreceptor Cell Death Induced by SNP Is Mediated
by an Increase in Intracellular Ca2 Levels and Calpain Acti-
vation—In the cell, oxidative stress induces Ca2 influx from
the extracellular environment and efflux from intracellular
FIG. 1. SNP-induced RNI and ROS
production and apoptotic cell death
in the photoreceptor cell line 661W.
661W cells were treated with increasing
concentrations of SNP (0.1–0.5 mM) for
20 h. A, the presence of nitric oxide me-
tabolites was detected colorimetrically by
the Griess reaction. The error bars corre-
spond to the S.D. of three independent
experiments done in duplicate. B, super-
oxide anion levels were quantified by flow
cytometry using the probe DHE prior to
SNP treatment (0 mM) and after treat-
ment with 0.1–0.5 mM SNP. The percent-
age of cells displaying increased levels of
ROS is shown at each SNP concentration.
Results are representative of three inde-
pendent experiments done in duplicate.
C, cell death measurements were done by
flow cytometry using propidium iodide.
Dot plots show that treatment of 661W
photoreceptor cells with the nitric oxide
donor SNP induced oxidative stress, lead-
ing to cell death. Results are representa-
tive of three independent experiments
carried out in duplicate. FSC-H, forward-
angle light scatter.
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stores, leading to an increase in cytoplasmic Ca2 levels, which
has been associated with apoptosis in diverse in vivo and in
vitro systems (32). It has also been shown that elevated cyto-
solic Ca2 levels play a role in rod photoreceptor apoptosis (11,
33, 34). In this study, intracellular Ca2 levels were deter-
mined using the fluorescent probe Fluo-3/acetoxymethyl ester.
To ensure that SNP treatment of 661W photoreceptor cells
increased [Ca2]i, calcium levels in untreated 661W cells were
compared with those in cells incubated with 0.3 mM SNP for
20 h. As depicted in the histogram in Fig. 2A, treatment of
661W cells with 0.3 mM SNP produced an increase in FL1
fluorescence, indicating an increased concentration of intracel-
lular calcium.
Activation of calcium-dependent proteases such as calpains
is thought to play an important role in certain models of oxi-
dative stress-induced apoptosis (35–37). In addition, several
studies have shown that calpains can contribute to neuronal
death (38–40), and calpain inhibitors have been used to block
apoptosis (41–43). However, to date, little is known about the
involvement of calpains in photoreceptor cell death. Previous
work from this laboratory has reported the activation of cal-
pains during light-induced retinal degeneration (12). To verify
the activation of calpains in 661W cells following increased
levels of intracellular Ca2, we performed immunoblot analy-
ses using polyclonal antibodies against the calpain isoforms
m-calpain and -calpain. Moreover, we also analyzed the com-
mon small regulatory subunit of calpains, which is dissociated
in response to increased levels of cytosolic calcium (44). As
illustrated in Fig. 2B, a decrease in the total amount of m-
calpain was observed after a 24-h treatment of 661W cells with
0.3 mM SNP (50% cell death). The reduction in calpain levels
was even more evident after 48 h (76% cell death). Although
calpains require only an increase in [Ca2]i to become active,
the autoproteolytic cleavage further enhanced their activity.
Fig. 2B shows that SNP-treated 661W cells contained the au-
tolysed form of -calpain (78 kDa), indicating that this isoform
is also activated by SNP. Consistent with the results of the
immunoblot analysis of the latent forms of calpains, a decrease
in the intensity of the band corresponding to the calpain small
subunit (28 kDa) was observed after 24 h of treatment, whereas
after 48 h, the band was not detectable any longer. Western
blot analysis of the calpain substrate calpastatin was carried
out to confirm the activation of calpains. The complete disap-
pearance of the calpastatin band after 24 h of treatment
strongly indicates that calpains are involved in 661W photore-
ceptor death induced by SNP.
661W Photoreceptor Cell Death Induced by SNP Is Caspase-
dependent—It is well documented that caspases are the central
executioners of apoptosis in a wide range of cell types (45, 46).
Several reports have described a role for caspases during pho-
toreceptor apoptosis (9, 47). Tuohy et al. (26) recently reported
that apoptosis of 661W photoreceptors triggered by transfect-
ing the Fas-associated death domain is caspase-dependent. In
contrast, a lack of caspase activation has also been demon-
strated during retinal cell apoptosis (10). Work performed in
two in vivo models of photoreceptor apoptosis has also shown
that light-induced photoreceptor apoptosis and N-methyl-N-
nitrosourea-induced retinal cell apoptosis are caspase-inde-
pendent (11, 12, 16). Because oxidative stress appears to play a
key role in 661W cell death induced by SNP, we determined the
activation status of caspase-3, -9, and -12 by Western blot
analysis.
Caspase-12 is predominantly found as a proenzyme in the
endoplasmic reticulum (ER), and it has been recently demon-
strated that this caspase can mediate an ER-specific apoptotic
pathway (48). The activation of caspase-12 results from agents
or insults that affect ER homeostasis, and it has recently been
shown (35) that activation of m-calpain is required for pro-
caspase-12 processing. In view of the fact that we had observed
m-calpain activation in SNP-treated 661W cells, we investi-
gated whether caspase-12 is active. Fig. 3A demonstrates the
presence of two fragments at 38 kDa in 661W cells treated
FIG. 1—continued
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with a concentration of SNP of 0.3 mM for 24 h. The level of
these fragments was increased at 48 h, and also an additional
fragment appeared at 30/33 kDa at this time point. Moreover,
an increase in the level of full-length caspase-12 could be ob-
served in both time points. Although the molecular mass of the
active subunits of caspase-12 has not been precisely described,
previous work has referred to protein fragments at 35 kDa as
an indication of caspase-12 activation by m-calpain (35). There-
fore, our results indicate that caspase-12 is active in SNP-
treated 661W photoreceptor cells.
Caspase-9 is activated in response to stimuli that lead to
cytochrome c release from mitochondria and is essential for
initiation of the caspase cascade, involving caspase-2, -3, -6,
and -7 (49). Nitric oxide has been reported to induce mitochon-
drial permeability transition, which is supposed to cause the
liberation of apoptogenic factors from mitochondria (50, 51). In
our case, the elevated ROS levels detected in SNP-treated
611W cells suggested a mitochondrial dysfunction. Therefore,
to determine whether caspase-9 is active or inactive in our
system, 661W photoreceptor cells were incubated with 0.3 mM
SNP for 24 and 48 h prior to Western blot analysis. 661W cells
FIG. 2. Oxidative stress in 661W photoreceptor cells induces
increases in intracellular calcium levels and leads to activation
of m-calpain. A, intracellular Ca2 levels were monitored using the
fluorescent probe Fluo-3/acetoxymethyl ester in untreated 661W cells
and in cells incubated with 0.3 mM SNP for 20 h. A shift in the peak to
increased fluorescence in the FL1 channel indicates an increased level
of intracellular Ca2 in SNP-treated 661W cells. The histogram is
representative of three independent experiments done in duplicate. B,
shown are the results from immunoblot analysis of m- and -calpains,
their small regulatory subunit (28 kDa), and calpastatin. Western blot-
ting was performed using 661W cell lysates taken prior to SNP insult
(untreated (UT)) and 24 and 48 h after treatment with 0.3 mM SNP.
Polyclonal antibodies were used to detect activation of m- and -cal-
pains. The results were confirmed by dissociation of the small subunit
and detection of the calpain substrate calpastatin. After 24 and 48 h of
treatment, the calpastatin band (110 kDa) could not be detected, sug-
gesting calpain-mediated processing. The blot was reprobed with an
antibody to -actin to demonstrate equal protein loading. Analyses
were done in triplicate with similar results.
FIG. 3. Caspase-3, -9, and -12 are activated during 661W photo-
receptor apoptosis induced by SNP. A, cell lysates were taken from
661W cells 24 and 48 h after treatment with 0.3 mM SNP. Untreated
661W cells (UT) were used as negative control. The presence of 38-kDa
bands and a 30–33-kDa fragment in the blot indicates caspase-12
activation. B, activation of caspase-3, its substrate poly(ADP-ribose)
polymerase (PARP), and caspase-9 was analyzed by Western blotting.
Untreated 661W cells and 100 nM staurosporine-treated 661W cells (24
h) were used as negative (UT) and positive (PC) controls, respectively.
Procaspase-3 processing was verified after a 48-h treatment with SNP
by the presence of the 17-kDa active subunit on the blot. Detection of
the 85-kDa PARP fragment confirmed caspase-3 activation. Caspase-9
activation was demonstrated by the presence of its cleaved fragments
(39 and 37 kDa) after a 24-h treatment of 661W cells with 0.3 mM SNP.
All blots were reprobed with an antibody to -actin to demonstrate
equal protein loading. A representative result of three experiments is
shown on all immunoblots.
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treated with 100 nM staurosporine for 24 h were used as posi-
tive controls. The tyrosine kinase inhibitor staurosporine has
been shown to induce apoptosis in 661W cells following a mi-
tochondrial pathway in which caspase-3, -7, and -9 are active.2
The concentration of staurosporine was chosen to give a similar
percentage cell death as seen for 0.3 mM SNP. Caspase-9 is
synthesized as a 45-kDa inactive proenzyme and is cleaved to
generate active subunits of 39 and 37 kDa. The presence of the
39- and 37-kDa caspase-9 fragments after a 24-h incubation of
611W photoreceptor cells with a concentration of SNP of 0.3 mM
demonstrated the activation of caspase-9 (Fig. 3B).
Caspase-3 is considered the main executioner of apoptosis,
and the involvement of this enzyme in photoreceptor apoptosis
has been reported (47, 52, 53). Caspase-3 is synthesized as a
32-kDa proenzyme that requires cleavage by caspase-9 to its
17–19-kDa active subunits (49). As shown in Fig. 3B, the pres-
ence of cleaved caspase-3 fragments was not detected in 661W
cells after a 24-h treatment with 0.3 mM SNP. At this time
point, the Western blot revealed only a 29-kDa band under the
procaspase-3 unit. This fragment has been recently identified
as the cleaved product of procaspase-3 by m-calpain (54), which
supports our previous observations as previous results shown
in this work (Fig. 2B) suggesting that calpains are active in
SNP-induced photoreceptor apoptosis. After 48 h, the 17-kDa
active subunit of caspase-3 was visible on the blot, indicating
classical caspase-3 activation. This result demonstrates that
cleavage of procaspase-3 is a late event in the signaling cascade
triggered by SNP. The results from Western blot analysis show
that activation of calpains and caspase-9 took place 24 h ear-
lier, before processing of the executioner caspase-3 was de-
tected. To confirm caspase-3 activation, cleavage of the
caspase-3 substrate PARP was analyzed by Western blotting.
PARP can be cleaved by either calpains or caspase-3. A poly-
clonal antibody was used to detect both PARP and the 85-kDa
fragment resulting from caspase-3 cleavage (55). According to
the results obtained for caspase-3, the 85-kDa inactive subunit
of PARP was present only after a 48-h treatment with SNP
(Fig. 3B). In summary, the results obtained in the Western blot
analysis demonstrate that signaling mediated by both calpains
and caspases may be involved in SNP-induced 661W photore-
ceptor apoptosis. This is the first demonstration that both
caspases and calpains are involved in photoreceptor apoptosis.
The Broad-range Caspase Inhibitor Z-VAD-fmk Cannot In-
hibit SNP-induced Apoptosis in 661W Photoreceptor Cells—
Caspase inhibitors have been employed to block apoptosis in
cell systems in which caspases have a central role. In view of
the fact that SNP-induced apoptosis in 661W cells was caspase-
dependent, we examined the effect of Z-VAD-fmk on photore-
ceptor apoptosis. Therefore, 661W cells were preincubated with
Z-VAD-fmk prior to treatment with 0.3 mM SNP; and subse-
quently, caspase-3 activity was analyzed by cleavage of the
colorimetric substrate Ac-DEVD-pNA. As depicted in Fig. 4A,
preincubation of 661W cells with Z-VAD-fmk completely pre-
vented caspase-3 activation due to SNP treatment. However, a
parallel determination of cell death in those samples (Fig. 4B)
revealed that despite Z-VAD-fmk inhibition of caspase-3, the
pan-caspase inhibitor was unable to prevent SNP-induced apo-
ptosis in 661W photoreceptor cells. Moreover, the cell death
percentage estimated for Z-VAD-fmk-pretreated 661W cells
was significantly higher than that exhibited by those photore-
ceptors that had not been preincubated with the caspase inhib-
itor (61 and 53%, respectively). We have demonstrated that
both caspases and calpains are involved in photoreceptor apo-
ptosis. Therefore, our findings suggest that inhibition of
caspases in SNP-treated 661W photoreceptor cells activates a
more harmful death pathway, not necessarily apoptotic, in
which calpains could be the main executioners. Consistent with
this hypothesis, immunoblot analysis of m-calpain and its
small subunit in SNP-treated samples revealed that the pan-
caspase inhibitor Z-VAD-fmk did not inhibit calpain activity;
on the contrary, a slight increase in m-calpain activation was
observed under these conditions compared with samples
treated with only SNP, and no difference was observed in the
dissociation of the small regulatory subunit of calpain (Fig. 4C).
In view of these results, alternatives other than caspase inhib-
itors have to be found to inhibit apoptosis in 661W photorecep-
tor cells.2 V. Go´mez-Vicente and T. G. Cotter, unpublished data.
FIG. 4. The caspase inhibitor Z-VAD-fmk inhibits SNP-trig-
gered DEVD-like caspase-3 activity in 661W photoreceptor cells
but cannot prevent 661W cell apoptosis. The photoreceptor cell line
661W was incubated with 50 M Z-VAD-fmk for 1 h before treatment
with 0.3 mM SNP. Untreated (UT) and SNP-treated 661W cells were
used as negative and positive controls, respectively. A, Ac-DEVD-pNA
hydrolysis was monitored after a 24-h incubation at 37 °C and quanti-
fied colorimetrically at 405 nm. Results are expressed in arbitrary units
(absorbance of the sample divided by the absorbance of the UT cells). *,
significant difference compared with SNP-treated cells (t test; p 0.05).
B, cell death measurements were done by flow cytometry using pro-
pidium iodide. Error bars correspond to the S.D. of three independent
experiments carried out in duplicate. C, immunoblot analysis of m-
calpain and its small regulatory subunit (28 kDa) shows increased
calpain activity in 661W cells pretreated with Z-VAD-fmk.
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CR-6 Acts as a Scavenger of ROS and Reduces Cell Death in
661W Photoreceptor Cells Induced by SNP—CR-6 could be en-
visaged as a simple tocopherol analog. In addition to a phenol
moiety, its structure contains two non-substituted and highly
activated aromatic positions that confer upon the molecule the
ability to react with radical species. Thus, the capacity of CR-6
to react with nitrating species such as NO and ONOO has
already been demonstrated; moreover, CR-6 has been shown to
prevent glutamate neurotoxicity in primary cultures of cerebel-
lar neurons by scavenging NO (27). Therefore, CR-6 appealed
to us as a worthwhile candidate to study the effect of pretreat-
ment with an antioxidant molecule on 661W cell death induced
by SNP since we had already observed that RNI and ROS were
involved in 661W cell apoptosis. 661W cells were preincubated
for 15 min with increasing concentrations of CR-6 (0.2–100 M).
Then, 0.3 mM SNP was added to the wells, and incubation was
continued for 20 h. A significant reduction in cell death was
observed when 661W cells were pretreated with high concen-
trations of CR-6 (100 to 12.5 M). Thus, after a 15-min incuba-
tion with 25 M CR-6 cell death was reduced in 63% of the cells.
Moreover, the protecting capacity exhibited by CR-6 in 661W
cells was superior to that of other assessed antioxidants (butyl-
ated hydroxytoluene, resveratrol, ascorbic acid, and N-acetyl-
L-cysteine) and similar to that of -tocopherol (data not shown).
As a result of this study, a CR-6 concentration of 25 M was
chosen for further assays. We then tested whether CR-6 pre-
vents cell death when 661W cells are incubated with increasing
concentrations of SNP. We also assessed whether CR-6 acts as
a scavenger of radical species. As depicted in Fig. 1A, the
presence of nitric oxide metabolites was determined colori-
metrically using the Griess reaction, whereas the generation of
superoxide anions was monitored using the probe DHE. Fig. 5A
illustrates the results of these experiments. As shown in panel
a, preincubation of 661W cells with 25 M CR-6 significantly
prevented cell death at all concentrations of SNP studied. It
should be noted that the percentage of cell death was reduced
to basal levels in those samples pretreated with CR-6 and
preincubated with 0.1 and 0.2 mM SNP. Therefore, CR-6 con-
fers complete protection against apoptosis induced by low con-
centrations of SNP in 661W photoreceptor cells under the
conditions tested. In the rest of the samples, the protection
achieved varied from 70 to 50% when cells were insulted with
0.3 and 0.5 mM SNP, respectively. Panel b illustrates the re-
duction of superoxide anion levels in all samples that had been
pretreated with CR-6, although the decrease in the ROS levels
was more significant at high concentrations of SNP (46 and
40% reduction for samples pretreated with 25 M CR-6 and
incubated with 0.4 and 0.5 mM SNP, respectively). The ability
of CR-6 to scavenge superoxide anions has not been described
previously. However, previous work has demonstrated that
CR-6 exhibits a potent inhibitory activity of lipid peroxidation
induced in rat liver microsomes, which could constitute evi-
dence of ROS scavenging by CR-6 (56). Moreover, it has been
suggested that scavenging of ROS could have been a contribu-
tion to the protective effect exhibited by CR-6 in primary cul-
tures of cerebellar neurons (27). Panel c illustrates the pres-
ence of nitrites in 661W control cells treated with increasing
concentrations of SNP and in those pretreated with CR-6. Sur-
prisingly, an increase in nitrites was detected in all cases. Ini-
tially, a decrease in RNI would have been expected if CR-6 had
trapped these radicals. However, despite the increased levels of
nitrites observed, scavenging of RNI by CR-6 cannot be discarded
since the increase in nitrite concentration could be the result of
the reaction between CR-6 and nitric oxide or peroxynitrites.
Annexin V staining of 661W cells clearly showed that treat-
ment with 0.3 mM SNP for 20 h was enough to increase phos-
phatidylserine exposure at the surface of the cell compared
with untreated cells (Fig. 5B). Dot plots from the fluorescence-
activated cell sorter analysis of annexin V-stained cells are
divided in four different quadrants. The lower quadrants show
those cells not stained with propidium iodide, i.e. with intact
membranes. The lower left quadrants show the annexin V-
negative propidium iodide-negative population, whereas the
lower right quadrants shows the annexin V-positive propidium
iodide-negative cell population. The upper quadrants display
cells that have lost membrane integrity and have become pro-
pidium iodide-positive. The percentages of cell counts in the
lower quadrants are indicated with numbers. Thus, in panel a
(untreated cells), the annexin V-negative propidium iodide-
negative cell population counts for 89% of the whole cells,
whereas only 5% of the total cell population is annexin V-
positive. Treatment with 0.3 mM SNP for 20 h shifted the
annexin V-positive population to 15.2% (panel b). Nevertheless,
a 15 min-incubation of 661W cells with 25 M CR-6 was enough
to completely reverse the annexin V-positive percentage to
4.6% (panel c). Therefore, under these conditions, CR-6 confers
substantial protection against SNP-induced phosphatidyl-
serine exposure.
CR-6 Can Reduce Increases in Intracellular Calcium Levels
and Prevent m-calpain Activation in 661W Photoreceptor Cells
Treated with SNP—We have shown above that oxidative stress
in 661W cells due to treatment with SNP led to an increase in
cytosolic Ca2 levels, which subsequently activated calpains.
Since CR-6 traps ROS, reducing the oxidative stress in SNP-
treated cells, we considered it worthwhile to investigate the
downstream effects that scavenging of ROS by CR-6 could have
in SNP-treated 661W photoreceptors. Thus, the cytosolic Ca2
levels were measured in control cells (cells treated for 20 h) and
in cells pretreated with 25 M CR-6 for 15 min. As expected,
CR-6 partially inhibited the increase observed in intracellular
Ca2 levels induced by SNP treatment at all concentrations
analyzed (Fig. 6A). Although oxidative stress has been de-
scribed as one of the causes of increased [Ca2]i in the cell,
other agents can generate an increase in intracellular Ca2
concentration as well. For example, Bcl-2 family proteins, in
addition to other apoptotic factors such as activated caspases,
may also have control over the Ca2 levels in cells (57, 58). This
fact suggests that other agents could be involved in the in-
creased calcium concentration observed in SNP-treated 661W
cells and could explain why CR-6 scavenging of ROS cannot
completely reduce the intracellular calcium concentration to its
basal level, at least at the lowest concentrations of SNP tested.
To investigate whether CR-6 can prevent calcium-mediated
calpain activation, control cell samples treated with 0.3 mM
SNP for 24 and 48 h were compared with cell samples incu-
bated with 25 M CR-6 for 15 min by Western blot analysis. Fig.
6B shows that CR-6 pretreatment of 661W cells prevented
m-calpain activation since 661W photoreceptors incubated
with CR-6 did not show the 58-kDa band corresponding to
active m-calpain. To ensure that CR-6 prevents calpain activa-
tion, we studied the extent of calpastatin cleavage in 661W
cells pretreated with CR-6 before insult with SNP. As illus-
trated in Fig. 6B, CR-6 completely abolished calpastatin cleav-
age when 661W photoreceptors were treated with SNP for 24 h.
At 48 h, CR-6 only partially attenuated calpastatin cleavage.
These results correlate very well with previous observations.
After a 24-h treatment with 0.3 mM SNP, the 661W cell death
percentage was 50%. Pretreatment of photoreceptors with
CR-6 prevented cell death by 70%. However, at the 48-h time
point, the cell death percentage was comparable with that
caused by 0.5 mM SNP treatment; and under these conditions,
cell death could be prevented only by 49%.
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CR-6 Prevents Caspase-12 Processing while Partially Inhib-
iting Caspase-3 and Caspase-9 Cleavage—The observation that
CR-6 prevented m-calpain cleavage led us to assay whether
caspase-12 processing is inhibited as well. Immunoblotting was
performed with 661W control photoreceptors (0.3 mM SNP in-
sult for 24 and 48 h) and with those pretreated with 25 M CR-6
(Fig. 7A). As expected, since m-calpain activated caspase-12,
pretreatment of 661W cells with CR-6 also prevented
caspase-12 activation. The 33-kDa cleavage band observed af-
ter treatment with 0.3 mM SNP for 24 h was not visible when
661W photoreceptors were incubated with the antioxidant
CR-6. Moreover, the increased intensity of the procaspase-12
band at the 24-h time point compared with the untreated cells
was completely restored to basal levels in CR-6-pretreated
FIG. 5. Pretreatment of 661W photoreceptor cells with CR-6 inhibits apoptosis induced by the NO donor SNP. A, 661W control cells
were treated with dose-dependent concentrations of SNP (0.1–0.5 mM) for 20 h (white bars). CR-6-pretreated cells were incubated for 15 min with
a 25 M concentration of the antioxidant before insult (black bars). CR-6 significantly reduced cell death induced by SNP at all concentrations
studied (panel a) due to the scavenging of superoxide anions (panel b). Results correspond to three different experiments done in duplicate; error
bars indicate the S.D. B, shown are the results from flow cytometric analysis of untreated 661W cells (panel a), 661W control cells treated with
0.3 mM SNP for 20 h (panel b), and 661W cells pretreated with 25 M CR-6 before SNP insult (panel c) and stained with annexin V and propidium
iodide (PI). Numbers in the corresponding quadrants indicate the percentage of cells present in the area. A reduction in the percentage of the
annexin V-positive population in those cells pretreated with CR-6 indicates the protective effect conferred by the antioxidant against phosphati-
dylserine exposure. The fluorescence-activated cell sorter analysis was repeated three times with similar results.
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photoreceptors. At 48 h, CR-6 also completely prevented
caspase-12 processing. Both the 33- and 38-kDa cleavage bands
were not present in 661W cells incubated with the antioxidant.
However, the basal levels of procaspase-12 were not completely
restored in this case, indicating that some stress was still
present under these conditions.
Following the analysis of caspase-12, we proceeded with the
study of the activation state of caspase-3 and caspase-9 when
SNP-treated 661W photoreceptors were preincubated with
CR-6 before insult. Fig. 7B illustrates the results obtained.
Activation of caspase-9 could not be prevented by CR-6, and
only at the 48-h time point could a slight recovery be observed
in the levels of the procaspase-9 band. According to the results
observed with caspase-9, caspase-3 activation was not pre-
vented by CR-6 pretreatment of 661W cells. As seen for
caspase-9, only a partial inhibition of procaspase-3 cleavage
FIG. 6. Effect of CR-6 on increased intracellular calcium levels
and calpain activation induced by SNP in 661W photoreceptor
cells. A, intracellular Ca2 levels were measured using the fluorescent
probe Fluo-3 in untreated cells (0 mM SNP; solid lines), in control cells
treated with dose-dependent concentrations of SNP (0.1–0.5 mM; dotted
lines in left panels), and in cells pretreated with 25 M CR-6 for 15 min
before insult with the corresponding SNP concentration (dotted lines in
right panels). The percentage of cells that showed increased Ca2 levels
in 661W photoreceptor cells induced by SNP treatment is indicated in
each panel. The histograms in the right panels illustrate the partial
inhibition of intracellular Ca2 increases by CR-6. A representative
result of three experiments is shown. B, shown are the results from
immunoblot analysis of m-calpain and its substrate calpastatin in
661W control cells and in cells pretreated with 25 M CR-6. Western
blotting was performed using equivalent quantities of total protein from
661W cell lysates taken prior to SNP insult (untreated (UT)) and 24 and
48 h after treatment with 0.3 mM SNP. The results show that m-calpain
activation could be prevented by pretreatment with CR-6. Results are
representative of three experiments.
FIG. 7. Effect of CR-6 on caspase-3, -9, and -12 activation status
in SNP-treated 661W photoreceptor cells. A, procaspase-12 proc-
essing was prevented by preincubating 661W photoreceptor cells with
the antioxidant CR-6 before insult with SNP. Cell lysates were taken
from 661W cells 24 and 48 h after treatment with 0.3 mM SNP. Un-
treated 661W cells (UT) were used as a negative control. B, CR-6 only
partially inhibited caspase-3 and caspase-9 activation. 661W cells
treated with 100 nM staurosporine for 24 h were used as a positive
control (PC). The presence of the cleaved caspase-9 fragments (39 and
37 kDa) when SNP-treated 661W cells were preincubated with 25 M
CR-6 demonstrates that the antioxidant could not prevent procaspase-9
processing. Accordingly with these results, caspase-3 activation was not
inhibited by CR-6 either. All blots were reprobed with an antibody to
-actin to demonstrate equal protein loading. A representative result of
three experiments is shown on all immunoblots. PARP, poly(ADP-
ribose) polymerase.
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was observed at the 48-h time point. The results obtained for
the caspase-3 substrate PARP agree with our previous obser-
vations. The 85-kDa cleavage band was still present at the 48-h
time point after pretreatment of 661W cells with CR-6. These
results indicate that the calpain-mediated apoptotic pathway
in 661W photoreceptors induced by SNP may run independ-
ently from the mitochondrial pathway and that CR-6 scaveng-
ing of ROS can prevent only the events triggered in the ER
(Fig. 8).
DISCUSSION
Oxidative Stress Generated by the Nitric Oxide Donor SNP
Induces in 661W Photoreceptor Cells Apoptotic Programmed
Death in Which Calpains and Caspases Are Involved—In this
study, we have explored the molecular events occurring after
induction of oxidative stress in 661W photoreceptor cells by
treatment with the nitric oxide donor SNP. Nitric oxide has
been reported to inhibit cytochrome oxidase, the terminal en-
zyme of the mitochondrial electron transport chain, leading to
the production of superoxide anions that can activate cell death
mechanisms (59). For example, it has been shown that nitric
oxide triggers cell death in neurons and that apoptotic events
are mediated by ROS (13, 60). In the same context, previous
work performed in this laboratory with an animal model has
also demonstrated that NO has a key role in retinal degener-
ation and that an early and rapid increase in intracellular ROS
accompanies retinal cell apoptosis in vivo (11). The data pre-
sented in this work are in agreement with previous observa-
tions and demonstrate that SNP induces ROS production in
661W photoreceptor cells, which activates the apoptotic cas-
cade, leading to cell death.
Elevation of cytosolic Ca2 levels has been reported to be a
key event in apoptosis (32). Studies performed in isolated rat
retinas have demonstrated that Ca2 overload can induce mi-
tochondrial depolarization and subsequently the release of apo-
ptosis-inducing factors (such as cytochrome c), which lead to
the sequential activation of caspase-9 and caspase-3 (34). Pre-
venting apoptosis in photoreceptors using calcium channels
blockers (12, 33) and calcium antagonist (61) has confirmed
these observations. In this study, intracellular calcium levels
were monitored after insult with dose-dependent concentra-
tions of SNP. An increase in the concentration of cytosolic
calcium was determined at every concentration of SNP studied
(Fig. 2A and 6B). Moreover, we noted that the increase ob-
served in the Ca2 level correlated with the percentage of
photoreceptor death.
Calpains are calcium-dependent proteases that have been
proposed to participate in apoptosis. Calpain activation during
apoptosis has been observed both in in vitro and in vivo sys-
tems (35, 36, 42, 62) Recently, a role for calpains in PC12 cell
apoptosis due to oxidative stress and increased calcium levels
has been demonstrated (36). However, to date little, is known
about the importance of calpains in retinal apoptosis, and the
molecular events they induce in photoreceptor cells have not
yet been defined. The results presented in this work provide
evidence of the contribution of calpains to photoreceptor apo-
ptosis. We have shown that calcium overload activated both m-
and -calpains in SNP-treated 661W photoreceptor cells (Fig.
2B). The dissociation of the small subunit of calpains, the
processing of the endogenous calpain inhibitor calpastatin, and
the truncation of procaspase-3 to a 29-kDa polypeptide (54)
have further supported the role of calpains in SNP-induced
661W photoreceptor apoptosis.
It has been demonstrated that photoreceptor cells from adult
mice can undergo caspase-independent cell death in vivo (10,
11). However, this study has illustrated that the caspase ma-
chinery is activated in 661W photoreceptor cells after insult
with SNP (Fig. 3). This apparent contradiction may be ex-
plained by the fact that in adult mice there is a significant
reduction in the expression of caspase-3 and caspase-9. Fur-
thermore, it has been shown the protein levels of apoptotic
protease-activating factor-1 also decrease with aging (12). This
can be the key reason why caspase-independent apoptosis is
seen in the retinas of these animals. Retinas from newborn
animals still express caspases and can undergo caspase-de-
pendent apoptosis. The 661W cell line is derived from the
retinas of 8-day postnatal mice. It is reasonable to expect the
caspase pathway to be active in SNP-treated 661W cells. In
addition, it has been reported that the nature and severity of an
insult determine whether apoptosis is caspase-dependent or
-independent (63). It is reasonable to conclude then that pho-
toreceptors are capable of caspase-dependent and -independent
cell death, with the initial insult and aging shaping the cellular
response. On the other hand, this study has shown for the first
time that photoreceptor cells can undergo an apoptotic pro-
grammed death in which calpains and caspases are involved.
There is growing evidence of cross-talk between caspases and
calpains, and it has been reported that calpain can mediate the
cleavage of caspase-3, -7, -8, -9, and -12 (35, 39, 54, 62, 64). We
have shown that inhibition of m-calpain prevented caspase-12
activation. The processing of procaspase-3 by m-calpain was
suggested by the presence of the 29-kDa fragment in 661W
cells 24 h post-insult with SNP.
CR-6 Acts as a Scavenger of ROS and Reduces 661W Photo-
receptor Cell Death Induced by SNP by Preventing the Activa-
tion of the Calpain-mediated Apoptotic Pathway—This study
has shown that even though the broad-spectrum caspase in-
hibitor Z-VAD-fmk prevented caspase-3 activation, it could not
inhibit SNP-induced 661W photoreceptor apoptosis (Fig. 4).
The fact that also calpains participated in 661W cell apoptosis
and were still active in the presence of Z-VAD-fmk (Fig. 4C)
could explain why the inactivation of caspases did not lead to
inhibition of apoptosis. On the other hand, the results pre-
FIG. 8. Schematic representation of the hypothetical events
that take place distal to treatment of 661W photoreceptor cells
with SNP. The nitric oxide donor SNP induces mitochondrial perme-
ability transition, which can cause release of apoptogenic factors such
as cytochrome c. Caspase-9 activation following apoptosome formation
leads to processing of downstream caspases. Simultaneously, the oxi-
dative stress generated by the SNP insult affects ER homeostasis,
which is reflected in increased intracellular calcium levels. The calcium-
dependent protease m-calpain is then activated. Subsequently,
caspase-12 processing occurs. Altogether, these events lead to the ap-
optotic death of 661W photoreceptor cells. The activation of the calpain-
mediated apoptotic pathway can be prevented by CR-6, which has been
demonstrated to scavenge ROS in SNP-treated 661W photoreceptors.
APAF 1, apoptotic protease-activating factor-1.
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sented in this work demonstrate that CR-6 reduced apoptosis
induced by SNP in 661W photoreceptor cells (Fig. 5A, panel a).
Our results show that incubation of 661W cells with CR-6 prior
to insult resulted in a decrease in superoxide anion levels,
indicating that CR-6 behaved as a ROS scavenger in our sys-
tem (Fig. 5A, panel b), which emphasizes the critical role of
ROS in photoreceptor apoptosis. In addition, CR-6 has been
demonstrated to have a very low toxicity in 661W photorecep-
tor cells (data not shown), which makes it an ideal candidate as
a potential therapeutic agent.
The downstream effects that CR-6 could have in SNP-treated
661W photoreceptors were investigated. In this section of the
study, we have shown that CR-6 scavenging of intracellular
ROS led to a reduction in the increased cytosolic calcium levels
induced by SNP treatment (Fig. 6A). The decrease observed in
the intracellular Ca2 concentration was reflected in m-calpain
inactivation (Fig. 6B), which in turn inhibited procaspase-12
processing (Fig. 7A). Therefore, CR-6 has been demonstrated to
be a useful tool to reduce oxidative stress-induced apoptosis in
661W cells and has allowed us to show the important role
played by calpains in photoreceptor apoptosis. Despite the in-
hibitory effect elicited by CR-6 in the calpain-mediated apo-
ptotic pathway, CR-6 scavenging of ROS could not prevent the
activation of the caspase-mediated mitochondrial pathway.
Only partial prevention of procaspase processing was observed,
most likely as a consequence of m-calpain inhibition (Fig. 7B).
In conclusion, the data presented here provide a possible mech-
anism by which oxidative stress mediates apoptosis in 661W
photoreceptor cells (Fig. 8). Moreover, our findings suggest a
central role for both caspases and calpains in the apoptotic
process. We have also shown that the inhibition of caspases
triggers an alternative mechanism of cell death in 661W cells
and that only prevention of calpain activation leads to a reduc-
tion of 661W photoreceptor apoptosis induced by SNP.
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